A phase I study of PXD101 (belinostat) in patients with unresectable hepatocellular carcinoma (HCC): a multicenter study by the Cancer Therapeutics Research Group (CTRG)
Refereed conference paper presented and published in conference proceedings


全文

其它資訊
著者YEO Winnie, CHAN Lam Stephen, MO Kwok Fai, LIM R, MA Buig Yue Brigette, HUI Pun Edwin, YU S, KOH Chun, CHAN Anthony Tak Cheung, GOH B C
會議名稱19th Conference of the Asian Pacific Association for the Study of the Liver
會議開始日13.02.2009
會議國家/地區中國
會議論文集題名19th Conference of the Asian Pacific Association for the Study of the Liver
出版年份2009
月份2
日期13
出版地China, Hong Kong
頁次p158
語言英式英語
關鍵詞hepatocellular carcinoma; PXD101

上次更新時間 2018-20-01 於 13:14